Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee
Completed · Not applicable
Conditions studied: Osteoarthritis
In brief
Randomized, double-blind, placebo controlled parallel group, multi center study in subjects with moderate-severe osteoarthritis.
Key facts
- Study ID
- NCT00435292
- Run by
- Primus Pharmaceuticals
- People needed
- 350
- Starts
- 2006-04-01
- Expected to finish
- 2007-12-01
- Last updated by the study team
- 2015-10-21
Who can join
Age: 35 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- OA of the Knee
- K-L Grade 2-3
- Positive response to NSAIDS
You may not qualify if…
- K-L grade 1 0r 4 OA of the knee
- History of GI Bleed within past 5 years
- Chronic bleeding disorder
Where it is running
- Primus Pharmaceuticals, Inc — Scottsdale, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.